Skip to main content
. 2017 Mar 28;112(6):1246–1257. doi: 10.1016/j.bpj.2017.01.033

Figure 3.

Figure 3

Quantification of BC-EC adhesion. (A–C) In adhesion assays, we quantified the percentage (mean ± SE) of 3 BCs (RT112 (A), T24 (B), and J82 (C)) adhering to ECs while blocking ICAM-1 on ECs and blocking MUC1, CD43, and MUC1+CD43 on cancer cells. One-way analysis of variance was performed to determine significance with respect to the control; ∗∗∗∗p ≤ 0.0001, ∗∗p ≤ 0.01.